Literature DB >> 25318830

Europium bis(dimethylsilyl)amides including mixed-valent Eu3[N(SiHMe2)2]6[μ-N(SiHMe2)2]2.

André M Bienfait1, Christoph Schädle, Cäcilia Maichle-Mössmer, Karl W Törnroos, Reiner Anwander.   

Abstract

Trivalent Eu[N(SiHMe2)2]3(THF)2 can easily be synthesized by applying a routine salt metathesis protocol (EuCl3(THF)2 and 3 equiv. of Li[N(SiHMe2)2] in n-hexane) which crystallizes isotypically to its analogues of the rare-earth metal series (space group P21/c). Transsilylamination of Eu[N(SiMe3)2]2(THF)2 with a slight excess of HN(SiHMe2)2 in n-hexane-THF yields the divalent trinuclear compound Eu{[μ-N(SiHMe2)2]2Eu[N(SiHMe2)2](THF)}2, the solid-state structure of which differs significantly from the samarium and ytterbium analogues by showing three unique molecules in the asymmetric unit of which one is related to the two others by an inversion. Using crude Eu[N(SiMe3)2]3 in transsilylamination reactions with HN(SiHMe2)2 in n-hexane afforded n-hexane-insoluble trivalent ate complexes {MEu[N(SiHMe2)2]4}n (M = Na, K) depending on the synthesis conditions of Eu[N(SiMe3)2]3. Performing the transsilylamination of Eu[N(SiMe3)2]3 with a large excess of HN(SiHMe2)2 at elevated temperatures gave reproducibly the donor-free, mixed-valent, trinuclear compound Eu(II){[μ-N(SiHMe2)2]Eu(III)[N(SiHMe2)2]3}2 in good yield.

Entities:  

Year:  2014        PMID: 25318830     DOI: 10.1039/c4dt02411g

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

Review 1.  Rare Earth Starting Materials and Methodologies for Synthetic Chemistry.

Authors:  Fabrizio Ortu
Journal:  Chem Rev       Date:  2022-01-31       Impact factor: 60.622

2.  Synthesis and crystallographic characterization of di-phenyl-amide rare-earth metal complexes Ln(NPh2)3(THF)2 and [(Ph2N)2 Ln(μ-NPh2)]2.

Authors:  Chad T Palumbo; Christopher M Kotyk; Joseph W Ziller; William J Evans
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2020-08-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.